Cite
HARVARD Citation
El Badri, S. et al. (2021). Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK study. Breast. pp. 199-205. [Online].